- Home
- KLRS vs RFM Comparison
KLRS vs RFM Comparison
Compare KLRS & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLRS | RFM |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.8M | 79.7M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KLRS | RFM |
|---|---|---|
| Price | $1.91 | $13.01 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $18.71 | N/A |
| AVG Volume (30 Days) | ★ 72.7K | 28.0K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $165,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $12.52 |
| 52 Week High | $11.88 | $15.03 |
Technical Indicators
Market Signals| Indicator | KLRS | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 16.80 | 43.31 |
| Support Level | N/A | $12.52 |
| Resistance Level | $4.37 | $14.94 |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | -0.04 | 0.06 |
| Stochastic Oscillator | 2.75 | 76.14 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.